Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, December 11, 2008

Acusphere’s Imagify rejected by FDA committee

By Mass High Tech staff

One day after the Nasdaq Global Market temporarily stopped trading of Acusphere Inc. common stock, the company’s heart imaging agent, Imagify for Injectable Suspension, was rejected by the U.S. Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee. The FDA cited concerns that the risks of the product outweigh the benefits of its diagnostic capabilities for detecting coronary artery disease, Acusphere (Nasdaq: ACUS) officials said.

The rejection from the FDA committee advisories does not necessarily translate to a rejection by the FDA itself in evaluating Imagify for its New Drug Application.

Imagify is an investigational injectable imaging drug that uses ultrasound to diagnose coronary artery disease. The ultrasound technique would provide an alternative to standard nuclear stress testing, company officials reported.

Watertown-based Acusphere has battled a tough year with multiple Nasdaq delisting warnings and layoffs of 24 employees, about a quarter of its staff, in July. The staff cuts are in the company’s manufacturing group responsible for making Imagify. In October, the company announced a $20 million debt offering agreement with biopharmaceutical firm Cephalon Inc. At the time, Acusphere CEO and president Sherri C. Oberg said in a statement that the agreement would help finance the FDA approval process of Imagify.

In September, Acusphere reported a quarterly net loss of $10.3 million on quarterly revenue of $340,000.





 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Flagsuit wins another NASA Astronaut Glove Challenge

Southwest Harbor, Maine's Peter Homer won $450,000 in NASA's Astronaut Glove Challenge yesterday. This is Homer's second time winning the contest. Homer's first win in 2007 launched his startup, Flagsuit. Flagsuit is developing pressure suits using the same technology as Homer's prizewinning gloves -- for use as a wearable substitute for hyperbaric chambers used to treat conditions such as ...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio